vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Finwise Bancorp (FINW). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $42.7M, roughly 1.5× Finwise Bancorp). Finwise Bancorp runs the higher net margin — 6.4% vs -70.9%, a 77.3% gap on every dollar of revenue. Over the past eight quarters, Finwise Bancorp's revenue compounded faster (47.0% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.
CTKB vs FINW — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $42.7M |
| Net Profit | $-44.1M | $2.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 6.4% |
| Revenue YoY | 8.1% | — |
| Net Profit YoY | -557.1% | — |
| EPS (diluted) | — | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $42.7M | ||
| Q4 25 | $62.1M | $46.9M | ||
| Q3 25 | $52.3M | $36.7M | ||
| Q2 25 | $45.6M | $25.1M | ||
| Q1 25 | $41.5M | $22.1M | ||
| Q4 24 | $57.5M | $21.1M | ||
| Q3 24 | $51.5M | $20.8M | ||
| Q2 24 | $46.6M | $19.8M |
| Q1 26 | — | $2.7M | ||
| Q4 25 | $-44.1M | $3.9M | ||
| Q3 25 | $-5.5M | $4.9M | ||
| Q2 25 | $-5.6M | $4.1M | ||
| Q1 25 | $-11.4M | $3.2M | ||
| Q4 24 | $9.6M | $2.8M | ||
| Q3 24 | $941.0K | $3.5M | ||
| Q2 24 | $-10.4M | $3.2M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 11.7% | ||
| Q3 25 | -17.6% | 17.5% | ||
| Q2 25 | -23.3% | 21.7% | ||
| Q1 25 | -36.1% | 20.1% | ||
| Q4 24 | 5.2% | 17.5% | ||
| Q3 24 | -8.2% | 22.2% | ||
| Q2 24 | -18.3% | 21.1% |
| Q1 26 | — | 6.4% | ||
| Q4 25 | -70.9% | 8.4% | ||
| Q3 25 | -10.5% | 13.3% | ||
| Q2 25 | -12.2% | 16.3% | ||
| Q1 25 | -27.5% | 14.4% | ||
| Q4 24 | 16.8% | 13.2% | ||
| Q3 24 | 1.8% | 16.6% | ||
| Q2 24 | -22.4% | 16.1% |
| Q1 26 | — | $0.20 | ||
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.29 | ||
| Q1 25 | — | $0.23 | ||
| Q4 24 | — | $0.19 | ||
| Q3 24 | — | $0.25 | ||
| Q2 24 | — | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $196.6M |
| Total Assets | $461.5M | $899.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $90.9M | $163.4M | ||
| Q3 25 | $93.3M | $105.6M | ||
| Q2 25 | $75.5M | $90.1M | ||
| Q1 25 | $95.3M | $120.3M | ||
| Q4 24 | $98.7M | $109.2M | ||
| Q3 24 | $162.3M | $85.8M | ||
| Q2 24 | $177.9M | $89.0M |
| Q1 26 | — | $196.6M | ||
| Q4 25 | $341.7M | $193.2M | ||
| Q3 25 | $378.6M | $187.8M | ||
| Q2 25 | $377.6M | $182.0M | ||
| Q1 25 | $379.6M | $177.4M | ||
| Q4 24 | $395.7M | $173.7M | ||
| Q3 24 | $385.5M | $170.4M | ||
| Q2 24 | $389.1M | $165.8M |
| Q1 26 | — | $899.4M | ||
| Q4 25 | $461.5M | $977.1M | ||
| Q3 25 | $494.9M | $899.9M | ||
| Q2 25 | $493.3M | $842.5M | ||
| Q1 25 | $482.6M | $804.1M | ||
| Q4 24 | $499.5M | $746.0M | ||
| Q3 24 | $491.2M | $683.0M | ||
| Q2 24 | $483.7M | $617.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $-28.4M | ||
| Q3 25 | $-3.9M | $3.5M | ||
| Q2 25 | $108.0K | $-18.3M | ||
| Q1 25 | $-125.0K | $-21.6M | ||
| Q4 24 | $2.0M | $-15.0M | ||
| Q3 24 | $13.2M | $-9.8M | ||
| Q2 24 | $6.2M | $-7.6M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $-28.6M | ||
| Q3 25 | $-4.6M | $3.4M | ||
| Q2 25 | $-1.5M | $-19.8M | ||
| Q1 25 | $-974.0K | $-23.3M | ||
| Q4 24 | $1.1M | $-16.1M | ||
| Q3 24 | $12.2M | $-13.4M | ||
| Q2 24 | $5.2M | $-7.7M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | -61.1% | ||
| Q3 25 | -8.7% | 9.4% | ||
| Q2 25 | -3.2% | -79.0% | ||
| Q1 25 | -2.3% | -105.3% | ||
| Q4 24 | 1.9% | -76.0% | ||
| Q3 24 | 23.7% | -64.3% | ||
| Q2 24 | 11.0% | -38.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 0.5% | ||
| Q3 25 | 1.3% | 0.1% | ||
| Q2 25 | 3.5% | 5.8% | ||
| Q1 25 | 2.0% | 7.4% | ||
| Q4 24 | 1.6% | 5.1% | ||
| Q3 24 | 2.0% | 17.2% | ||
| Q2 24 | 2.3% | 0.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | -7.26× | ||
| Q3 25 | — | 0.71× | ||
| Q2 25 | — | -4.48× | ||
| Q1 25 | — | -6.78× | ||
| Q4 24 | 0.21× | -5.37× | ||
| Q3 24 | 14.05× | -2.84× | ||
| Q2 24 | — | -2.39× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
FINW
| Net Interest Income | $28.1M | 66% |
| Noninterest Income | $14.6M | 34% |
